Navigation Links
Data suggests Abbott's test may help more accurately diagnose heart attacks in women
Date:9/4/2013

AMSTERDAM, Sept. 4, 2013 Abbott announced today promising preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive troponin test may help doctors improve the diagnosis and prognosis of patients presenting with symptoms of a heart attack.1 The test could be particularly beneficial for women, who may have different presenting symptoms and are often under-diagnosed.2 The study, which is being conducted by researchers at the University of Edinburgh, is evaluating Abbott's ARCHITECT STAT High Sensitive Troponin-I (hsTnI) test, which received CE Mark in January 2013.

Cardiac troponin, a protein found in the heart muscle, is considered the preferred biomarker to identify suspected heart attacks, because it can detect injury to the heart.3 Abbott's hsTnI test can measure very low levels of this protein, which is especially important for women, who often have lower levels of troponin than men.4

Researchers shared data from the first 1,126 patients of the study presenting with symptoms of a heart attack. Early findings demonstrate that women have lower peak levels of troponin than men, contributing to the under-diagnosis and therefore under-treatment of heart attacks for women.

"Whilst men and women are just as likely to present to the emergency department with chest pain, currently men are twice as likely to be diagnosed with a heart attack. By using the Abbott high sensitive troponin test and different diagnostic thresholds for men and women, the frequency of diagnosis of heart attacks in women increased and was comparable to men," said Dr. Nicholas Mills, one of the key study authors and cardiologist, University of Edinburgh. "The findings of our study, when completed, could change the way we diagnose heart attacks in women, potentially reducing inequalities in the treatment and outcomes, and enabling everyone to receive the best care."

When completed in 2016, this study will include more than 25,000 patients across 10 centers in Scotland, making it one of the largest studies to evaluate the impact of high sensitive troponin tests on patient care. The study was funded by a special project grant from the British Heart Foundation with Abbott providing the ARCHITECT STAT hsTnI assay.

"While Abbott's high sensitive troponin test benefits both men and women with earlier detection of heart attacks, the potential to increase the diagnosis among women is especially important," said John Frels, PhD, divisional vice president, Diagnostics Research, Abbott. "This is the first time we have seen a test that can provide this kind of detailed information to doctors and has the potential to aid doctors with improving the odds of survival for women with heart attacks."

The ARCHITECT STAT hsTnI assay is commercially available in several countries in Europe, as well as Canada, Australia, New Zealand, and Brazil and runs on Abbott's fully automated ARCHITECT family of analyzers. The test is currently for research-use only in the United States.


'/>"/>

Contact: Darcy Ross
847-937-3655
Fleishman-Hillard, Inc.
Source:Eurekalert

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study Suggests Treating Dyslexia Before Kids Learn to Read
3. Some Folks Just Cant Help Being Nice, Study Suggests
4. Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real
5. HIV Drug Tenofovir Safe During Pregnancy, Study Suggests
6. New study of NIH funding allocations suggests potential efficiency gains
7. Mens Breast Cancer Often More Deadly, Study Suggests
8. Zinc Pills May Shorten Colds, Analysis Suggests
9. Self-Managing COPD Might Pose Risks, Study Suggests
10. Parents are happier than non-parents, new research suggests
11. Discovery suggests new combination therapy strategy for basal-like breast cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... TX (PRWEB) , ... March 22, 2017 , ... ... insurance consultation, financial planning, and related services to communities across eastern Texas, is ... the goal of providing meals to hungry children and adults. , Consistently ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Zabbia Insurance Agency, a ... and business owners in the greater Nassau County area, is embarking on a ... Every 3 minutes, someone in America is diagnosed with blood cancer. Every 9 ...
(Date:3/22/2017)... Olathe, KS (PRWEB) , ... March 22, 2017 , ... ... Coach Bill Self still makes time for recruiting – that is, recruiting people to ... their hearts and homes to children who are in foster care due to abuse, ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... patient payments for providers while creating a positive patient experience. , HealthiPASS ... further educates and empowers patients by helping them understand their financial responsibility. ...
(Date:3/22/2017)... ... March 22, 2017 , ... Sharon Kleyne is the ... than two decades ago to research evaporation of earth’s and the body’s water vapor ... health. Also the host of the nationally syndicated radio program, The Sharon Kleyne Hour ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... Mar. 22, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 10.9% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/22/2017)... 2017 Serve You Rx Vermont, LLC, a wholly ... You), based in Milwaukee, Wisconsin , has ... in Middlebury, Vermont , from Pharmacy Health ... so it was perfect timing for this opportunity to present ... Serve You. "Like us, NEMOP has a high-touch service model, ...
(Date:3/22/2017)... Research and Markets has announced the addition of the ... Insight 2022" drug pipelines to their offering. ... Global Immune ... gives comprehensive insight on clinical and non-clinical aspects involved in ... main streamline drugs in the immunotherapy treatment. Report helps to ...
Breaking Medicine Technology: